Back
United Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
UTHR
United Therapeutics
Last Price:
$284.76
Seasonality Move:
4.96%
7 Day Trial
ALL ACCESS PASS
$
7

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing slight buying pressure.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 283.95 | Buy |
20-day SMA: | 298.3 | Sell |
50-day SMA: | 320.67 | Sell |
200-day SMA: | 345.36 | Sell |
8-day EMA: | 286.74 | Sell |
20-day EMA: | 296.09 | Sell |
50-day EMA: | 315.28 | Sell |
200-day EMA: | 327.32 | Sell |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.74 | Sell |
Relative Strength Index (14 RSI): | 37.49 | Sell |
Chaikin Money Flow: | 83209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (287.63 - 315.79) | Sell |
Bollinger Bands (100): | (312.63 - 373.13) | Sell |
United Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 284.73 while UTHR 8-day simple moving average is 283.95, which is a Buy signal.
-
The stock price of UTHR is 284.73 while United Therapeutics 20-day SMA is 298.30, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 320.67 while UTHR share price is 284.73, making it a Sell technically.
-
UTHR stock price is 284.73 and United Therapeutics 200-day simple moving average is 345.36, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
51
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $284.73. The Score for UTHR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
12.8B
Price in USD:
284.73
Share Volume:
302.9K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
233.28
Buy
51
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 284.73 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 284.73 while UTHR 8-day exponential moving average is 286.74, which is a Sell signal.
-
The stock price of UTHR is 284.73 while United Therapeutics 20-day EMA is 296.09, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 315.28 while UTHR share price is 284.73, making it a Sell technically.
-
UTHR stock price is 284.73 and United Therapeutics 200-day simple moving average is 327.32, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.40 per share, and an increase next year of $0.56 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -10.74, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 37.49, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (287.63 - 315.79), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (312.63 - 373.13), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.